Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Plos One|November 14, 2013
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV regionYacoob Mahomed Coovadia, Sharana Mahomed, Melendhran Pillay, et al.
The Journal of Infectious Diseases|July 1, 2020
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A ReviewSharana Mahomed, Nigel Garrett, Cheryl Baxter, et al.
The Journal of Molecular Diagnostics : JMD|April 5, 2026
Validation of a Low-Volume (100 μL) Plasma Protocol for HIV-1 RNA Quantification Using the Hologic Aptima HIV-1 Quant Dx AssayLorna S Madurai, Kiveshan Reddy, Someshni Nair, et al.
AIDS Research and Therapy|August 22, 2025
Optimizing syphilis screening in South Africa: efficacy of the iStatis antibody test in point-of-care settings amid reinfection challengesSharana Mahomed, Savathree Madurai, Someshni Nair, et al.
International Journal of STD & AIDS|June 14, 2026
Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South AfricaNivashnee Naicker, Lenine Liebenberg, Kunthi Naidoo, et al.
Pharmacogenomics|July 28, 2023
Single-nucleotide polymorphisms in ABC drug transporters alter expression and circulating tenofovir in healthy South African women exposed to pre-exposure prophylaxisNomusa M Zondo, Parveen Sobia, Aida Sivro, et al.
Scientific Reports|November 1, 2025
Decision-making and acceptability of subcutaneously administered broadly neutralising monoclonal antibodies for HIV prevention amongst CAPRISA 012A trial participants in Durban, South AfricaHilton Humphries, Hlengi Shozi, Zimasa Tshawe, et al.
AIDS Research and Therapy|February 15, 2025
Drug transporter mRNA expression and genital inflammation in South African women on oral pre-exposure prophylaxis (PrEP)Nomusa M Zondo, Parveen Sobia, Aida Sivro, et al.
Scientific Reports|June 12, 2024
Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trialParveen Sobia, Sharana Mahomed, Aida Sivro, et al.
Scientific Reports|June 19, 2026
Cervicovaginal microbiome diversity was not associated with mucosal pharmacokinetics of systemically delivered HIV broadly neutralizing antibodiesAndile Mtshali, Amadou Hamidou Togo, Asavela Kama, et al.
Pageof 4